Chemed Statistics
Total Valuation
Chemed has a market cap or net worth of $8.29 billion. The enterprise value is $8.27 billion.
| Market Cap | 8.29B |
| Enterprise Value | 8.27B |
Important Dates
The last earnings date was Wednesday, April 23, 2025, after market close.
| Earnings Date | Apr 23, 2025 |
| Ex-Dividend Date | Feb 24, 2025 |
Share Statistics
Chemed has 14.57 million shares outstanding. The number of shares has decreased by -1.41% in one year.
| Current Share Class | 14.57M |
| Shares Outstanding | 14.57M |
| Shares Change (YoY) | -1.41% |
| Shares Change (QoQ) | -1.52% |
| Owned by Insiders (%) | 1.57% |
| Owned by Institutions (%) | 95.94% |
| Float | 14.33M |
Valuation Ratios
The trailing PE ratio is 27.73 and the forward PE ratio is 21.95. Chemed's PEG ratio is 2.14.
| PE Ratio | 27.73 |
| Forward PE | 21.95 |
| PS Ratio | 3.41 |
| Forward PS | 3.13 |
| PB Ratio | 7.02 |
| P/TBV Ratio | 19.52 |
| P/FCF Ratio | 26.33 |
| P/OCF Ratio | 22.68 |
| PEG Ratio | 2.14 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 18.44, with an EV/FCF ratio of 26.24.
| EV / Earnings | 26.77 |
| EV / Sales | 3.32 |
| EV / EBITDA | 18.44 |
| EV / EBIT | 21.23 |
| EV / FCF | 26.24 |
Financial Position
The company has a current ratio of 1.73, with a Debt / Equity ratio of 0.12.
| Current Ratio | 1.73 |
| Quick Ratio | 1.58 |
| Debt / Equity | 0.12 |
| Debt / EBITDA | 0.28 |
| Debt / FCF | 0.46 |
| Interest Coverage | 231.21 |
Financial Efficiency
Return on equity (ROE) is 26.11% and return on invested capital (ROIC) is 18.32%.
| Return on Equity (ROE) | 26.11% |
| Return on Assets (ROA) | 14.09% |
| Return on Invested Capital (ROIC) | 18.32% |
| Return on Capital Employed (ROCE) | 27.12% |
| Revenue Per Employee | $158,585 |
| Profits Per Employee | $19,671 |
| Employee Count | 15,695 |
| Asset Turnover | 1.44 |
| Inventory Turnover | 175.37 |
Taxes
In the past 12 months, Chemed has paid $101.92 million in taxes.
| Income Tax | 101.92M |
| Effective Tax Rate | 24.82% |
Stock Price Statistics
The stock price has decreased by -1.07% in the last 52 weeks. The beta is 0.59, so Chemed's price volatility has been lower than the market average.
| Beta (5Y) | 0.59 |
| 52-Week Price Change | -1.07% |
| 50-Day Moving Average | 589.43 |
| 200-Day Moving Average | 570.77 |
| Relative Strength Index (RSI) | 44.86 |
| Average Volume (20 Days) | 133,612 |
Short Selling Information
The latest short interest is 239,006, so 1.64% of the outstanding shares have been sold short.
| Short Interest | 239,006 |
| Short Previous Month | 289,438 |
| Short % of Shares Out | 1.64% |
| Short % of Float | 1.67% |
| Short Ratio (days to cover) | 1.71 |
Income Statement
In the last 12 months, Chemed had revenue of $2.49 billion and earned $308.74 million in profits. Earnings per share was $20.53.
| Revenue | 2.49B |
| Gross Profit | 866.66M |
| Operating Income | 389.36M |
| Pretax Income | 387.17M |
| Net Income | 308.74M |
| EBITDA | 448.32M |
| EBIT | 389.36M |
| Earnings Per Share (EPS) | $20.53 |
Balance Sheet
The company has $173.88 million in cash and $145.06 million in debt, giving a net cash position of $28.82 million or $1.98 per share.
| Cash & Cash Equivalents | 173.88M |
| Total Debt | 145.06M |
| Net Cash | 28.82M |
| Net Cash Per Share | $1.98 |
| Equity (Book Value) | 1.18B |
| Book Value Per Share | 81.09 |
| Working Capital | 211.83M |
Cash Flow
In the last 12 months, operating cash flow was $365.69 million and capital expenditures -$50.65 million, giving a free cash flow of $315.04 million.
| Operating Cash Flow | 365.69M |
| Capital Expenditures | -50.65M |
| Free Cash Flow | 315.04M |
| FCF Per Share | $21.62 |
Margins
Gross margin is 34.82%, with operating and profit margins of 15.64% and 12.40%.
| Gross Margin | 34.82% |
| Operating Margin | 15.64% |
| Pretax Margin | 16.50% |
| Profit Margin | 12.40% |
| EBITDA Margin | 18.01% |
| EBIT Margin | 15.64% |
| FCF Margin | 12.66% |
Dividends & Yields
This stock pays an annual dividend of $2.00, which amounts to a dividend yield of 0.35%.
| Dividend Per Share | $2.00 |
| Dividend Yield | 0.35% |
| Dividend Growth (YoY) | 20.25% |
| Years of Dividend Growth | 10 |
| Payout Ratio | 9.74% |
| Buyback Yield | 1.41% |
| Shareholder Yield | 1.76% |
| Earnings Yield | 3.72% |
| FCF Yield | 3.80% |
Analyst Forecast
The average price target for Chemed is $674.00, which is 18.43% higher than the current price. The consensus rating is "Buy".
| Price Target | $674.00 |
| Price Target Difference | 18.43% |
| Analyst Consensus | Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on May 12, 2005. It was a forward split with a ratio of 2:1.
| Last Split Date | May 12, 2005 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
Chemed has an Altman Z-Score of 13.96 and a Piotroski F-Score of 4.
| Altman Z-Score | 13.96 |
| Piotroski F-Score | 4 |